Browse by Track

3-199 - A national survey regarding factors affecting student decision on which pharmacy school to attend

6-272 - A Systematic Review of Medicare Advantage versus Traditional Medicare in the Nursing Home Population

8-037 - Activity to reduce dispensing error for diminishing patient safety accident

5-200 - Allocation of inventory to automated dispensing cabinets and its impact on carousel dispense workload

5-274 - Alteration of pharmacy organization in a community hospital to optimize storage and workflow

5-158 - Analysis of STAT pediatric medication delivery at a children’s hospital within a large academic medical center

2-281 - Antibiotic shortages around the world

5-263 - Assessing Nursing Perception of the Implementation of New Automated Dispensing Cabinets

2-440 - Assessing pharmacist full time equivalents (FTE) for patient care demand in a team based primary care setting

3-275 - Assessing student satisfaction of career fair workshops aimed at prospective employment opportunities

3-167 - Assessing the impact of an incentive program on pharmacy staff attitude towards bedside delivery

3-158 - Assessing the use of sugammadex in a large health system

6-331 - Assessment of sub-wholesaler acquisition cost (sub-WAC) opportunities and implementation of associated cost saving strategies at an academic medical center

3-141 - Characterization and quantification of time devoted by hospital personnel to drug shortage management at a large academic medical center

8-156 - Complexity of pharmacy efforts in managing investigational drugs: a comparison of sponsored oncology vs. sponsored non-oncology trials

3-203 - Coordination of the bedside delivery workflow through implementation of a centralized triage technician at a large, academic medical center

3-205 - Cost and labor savings associated with stat cart processing optimization

6-290 - Cost effectiveness of fixed versus traditional dosing of prothrombin complex concentrate for the reversal of major bleeding: a retrospective review

3-314 - Cost sensitivity analysis comparing the use of neostigmine/glycopyrrolate and sugammadex for neuromuscular blockade reversal in patients with reversal failure

8-095 - Cost-avoidance through redistribution of short-dated emergency drug box medications

2-443 - Cost-minimization analysis of a rapid diagnostic PCR meningitis and encephalitis panel in the hospital setting

8-415 - Creating a culture of mindfulness to decrease burnout in ambulatory care pharmacists

2-135 - Describing high-cost prescription medications users: results from the Medical Expenditures Panel Survey

2-352 - Development and implementation of a pharmacy technician career ladder using an electronic portfolio

8-380 - Development and utilization of an inpatient pharmacy throughput capacity dashboard at an academic medical center

2-431 - Enhancement of the medication distribution process to patient care units in a community hospital

2-289 - Ernest Mario School of Pharmacy (EMSOP) preceptors’ perceptions on business mergers and their effect on the profession and patient care

6-205 - Evaluating community health assessment (CHA) and its utility in guiding future pharmacy practice and health care system evolvement in an urban hospital

8-321 - Evaluation of pharmacist and pharmacy intern patient education services in an inpatient setting

5-161 - Evaluation of pharmacy technician workload in an inpatient satellite pharmacy at a large academic medical center

2-001 - Evaluation of the Impact of Limited Distribution Networks on 340B Entities And Their Patients

5-198 - Expansion of clinical pharmacy services: initiation of a patient education program with student support

6-385 - Financial opportunities due to formulary review and optimization

5-324 - Gap analysis for the creation of a controlled substance diversion prevention program (CSDPP) at a quaternary-care academic health center

2-015 - Getting everybody on the same (formulary) page: merging institutional formularies in a system

5-092 - Hidden cost: compounded medication waste in an infusion pharmacy

8-086 - Identifying potential cost savings with industry sponsored patient assistant programs for patients receiving immunotherapy agents in an outpatient oncology clinic.

2-008 - Impact of clinical scorecard on pharmacy residents’ patient care performances

5-311 - Impact of leveraging technology in the ambulatory care setting in a Veterans affairs medical center

8-208 - Impact of objective structured clinical examination (OSCE) variation on potential lab leak

2-191 - Impact of PhORCAS letter of recommendation scores on application ranking for University of Kentucky HealthCare Postgraduate Year 1 Pharmacy candidates

5-089 - Impact of standardized narcotic surveillance process as part of a health-system pharmacy program

3-321 - Implementation of a carousel in a community hospital: the lessons learned

5-292 - Implementing workload capture of inpatient clinical pharmacists at a rural Veterans Affairs medical center

2-222 - Influenza Vaccination Requirements Among Healthcare Employees- A Snapshot of Healthcare Facilities in Montana

5-170 - Optimization of medication delivery routes in an inpatient pharmacy using multiple delivery routes and modes of transportation

5-018 - Perceptions of job and workplace satisfaction among community pharmacists in the Tucson area

3-356 - Pharmacists’ job satisfaction in the state of Utah

2-042 - Predictive factors in achieving high grade point average among Ethiopian diaspora students enrolled in the nontraditional Doctor of Pharmacy program at Howard University

5-056 - Probability of a positive urine culture from a urine analysis

8-301 - Review of patient reported outcome (PRO) measures for novel drug approvals (NDA) in the United States: 2016-2018

2-280 - SO-ACT: survey of obstacles to the administration of clinical trials

5-212 - Student pharmacists’ clinical interventions in Advanced Pharmacy Practice Experiences at a federally-qualified health center

5-173 - Student Pharmacists’ Perceptions on Curricular Enhancements to Improve Advanced Pharmacy Practice Experience (APPE)- Readiness

2-425 - The Revision of IV Room Inventory Management Through the Implementation of a Kanban System

6-191 - Validation of a scorecard tool to define specialty medications

2-086 - Value-based contracting: overview, current state, and future trends

3-089 - What a pharmacist does: a time and motion study

2-234 - A multidisciplinary approach to improving glycemic control in an underinsured low income population

3-033 - A1C improvement after 3 months in endocrinologist-pharmacist diabetes management program

2-356 - Acute Kidney Injury with Dulaglutide GLP-1 Receptor Agonist: A Case Report

6-252 - Age-related changes that affect medication management: the pharmacist’s role

8-221 - Altered thyroid function tests (TFTs) and unnecessary thioamide therapy following treatment with high-dose biotin (300 mg)

6-258 - Alternative to diabetes screening other than A1c in patients with cold agglutinin hemolytic anemia

8-193 - Ambulatory care pharmacists’ impact on improving health outcomes in patients with uncontrolled diabetes in a primary care setting

8-245 - An extended evaluation of weight gain in patients on rilpivirine for treatment of HIV-1 infection

2-448 - Analysis of alprazolam prescribing in primary care at the Cheyenne Veterans Affairs Medical Center

5-313 - Analysis of food deserts and treatment of hypertension, dyslipidemia, and diabetes mellitus

2-415 - Analysis of the impact of insurance availability on blood pressure in community health clinics in Ekumfi, Ghana

5-117 - Antibiotic prescribing patterns for acute pharyngitis and sinusitis

6-313 - Appropriateness of inhaled corticosteroid treatment for primary care patients with chronic obstructive pulmonary disease (COPD)

3-426 - Assessing appropriateness of treatment regimens for patients with chronic obstructive pulmonary disease in a rural ambulatory care setting

8-413 - Assessing diabetes management by interprofessional care coordination across a patient centered medical home.

3-192 - Assessing differences in tobacco use quit rates among veterans prescribed varenicline at the New Mexico VA Health Care System

3-024 - Assessing patient satisfaction with clinical pharmacist services at an ambulatory human immunodeficiency virus (HIV) clinic

5-275 - Assessing pharmacist-led interventions in sustaining diabetes control greater than one year

6-243 - Assessing the impact of a 2-year immunization outreach program within the Greater Boston area

6-255 - Assessing the impact of a regional multicultural outreach initiative through the American Pharmacists Association-Academy of Student Pharmacists: a pilot program

3-251 - Assessing vaccination rates for influenza, pneumonia, and hepatitis B in patients with type two diabetes mellitus in a federally qualified health center

8-312 - Assessment of adverse events in ambulatory diabetic patients treated with sodium-glucose co-transporter 2 (SGLT2) inhibitors in a hospital-based clinic

2-320 - Assessment of appropriate new oral anticoagulants use in the outpatient setting of a rural Native American population

3-094 - Assessment of GLP-1 receptor agonist treatment patterns in a pharmacist-managed collaborative diabetes medication management service

6-167 - Assessment of medication use among underserved patients experiencing a care transition

6-307 - Assessment of opportunities for clinical pharmacy intervention for a physician-pharmacist co-visit model

5-199 - Assessment of opportunities for clinical pharmacy intervention for regularly scheduled primary care patients in a family medicine practice

3-168 - Assessment of perceptions and utilization of apple cider vinegar (ACV) among pharmacists and pharmacy students

5-184 - Assessment of QTc prolongation monitoring in patients starting oral oncolytics

2-322 - Assessment of readiness to quit tobacco use among patients on an international, medical mission trip

6-399 - Assessment of telephone outreach program led by student pharmacists to improve medication adherence

6-102 - Assessment of the time lapse associated with accessing medications through a manufacturer medication assistance program

2-456 - Association between weight loss and prediabetes progression to diabetes at Cheyenne UW Family Medicine: a retrospective cohort study

6-321 - Blood pressure management in patients with human immunodeficiency virus

6-199 - Case report on significantly improved glycemic control with semaglutide

6-423 - Characterization of deprescribing intervention outcomes in elderly patients: A scoping review

6-432 - Characterization of lost revenue due to lack of billing for pharmacy clinical services

2-314 - Clinical outcomes associated with an interprofessional post-hospital discharge clinic visit

3-045 - Clinical Outcomes of type 2 diabetes patients with mental health comorbidities managed in a pharmacist-endocrinologist collaborative diabetes intense medical management (DIMM) “tune up” clinic

3-368 - Comparative analysis of impact of pharmacist engagement with providers in chronic pain management

8-109 - Comparison of glycemic control pre and post-treatment of hepatitis C in a Veteran population with type 2 diabetes mellitus

8-022 - Comparison of the utilization of a consult-based clinical pharmacy service in an academic family medicine clinic home after one year

5-345 - Correlation between a healthcare provider’s cultural competence and glycemic control in type 2 diabetics of Asian and Hispanic descent

3-380 - Creation of a pharmacist led diabetes support group in an urban, underserved population

2-396 - Description of medical services on a pharmacy-driven, short-term medical mission trip in Guatemala

2-030 - Developing a Patient Satisfaction Survey

3-110 - Development and implementation of a pilot pharmacist-driven outpatient interprofessional rounding service within a federally qualified health center (FQHC)

6-200 - Development and implementation of a PY4 led, faculty supervised medication refill clinic

3-387 - Development of a monitoring tool to identify pregnant women with epilepsy for early and frequent monitoring of antiepileptic drug regimens

6-436 - Development of an outpatient antibiogram for urinary pathogens at a free health care clinic

8-133 - Documentation of pharmacist medication reconciliation services at two ambulatory transitions of care clinics

5-155 - Drugs, diseases and deferrals in blood donations: a role for pharmacists

6-437 - Effect of a pharmacist-physician collaborative practice model on emergency department visits and blood pressure measurements in an urban safety net clinic

5-088 - Effect of incorporating community health workers into the medication use process for hypertensive patients in a culturally diverse population

6-020 - Efficacy of hepatitis B vaccinations for patients with chronic kidney disease

5-048 - Efforts to improve vaccination rates in Veterans via pharmacy student interventions

8-028 - Evaluating impact of a quality initiative in a federally qualified health center in order to address gaps in hypertension control resulting from new guidelines

3-103 - Evaluating Provider and Patient Satisfaction of an Interprofessional Comprehensive Diabetes Management Program (CDMP) in a Patient-Centered Medical Home

2-219 - Evaluating the impact of collaborative healthcare on uncontrolled diabetes

8-329 - Evaluating the impact of pharmacist interventions on the health outcomes of patients enrolled in a medication management clinic

6-250 - Evaluating the use of FreeStyle Libre in patients with type 1 and type 2 diabetes

3-114 - Evaluation of a group clinic offered in a Federally Qualified Health Center for patients living with chronic obstructive pulmonary disease

6-302 - Evaluation of a naloxone coprescribing initiative in a primary care clinic

8-360 - Evaluation of a pharmacist-led transitions of care pilot program in a primary care practice

3-396 - Evaluation of an interprofessional training program within the Department of Veterans Affairs through qualitative analysis

6-147 - Evaluation of appropriate initiation of antidepressants for major depressive disorder and assessment of use after 84 and 180 days in a primary care clinic

2-221 - Evaluation of baseline data of patients suffering from depression and anxiety in order to design a pharmacist driven follow-up protocol at a student health center

6-439 - Evaluation of clinical outcomes in a pharmacist-run diabetes clinic

8-277 - Evaluation of current prescribing patterns of statin therapy in diabetic patients

6-366 - Evaluation of flash continuous glucose monitoring in patients with type 1 and 2 diabetes

8-291 - Evaluation of hepatitis C in a primary care center

5-287 - Evaluation of HMG-CoA reductase inhibitor management among adult patients with low Low-density lipoproteins (LDL) at a federally qualified health center

3-366 - Evaluation of impact of ambulatory care pharmacist and community pharmacy partnership on medication adherence

6-284 - Evaluation of interventions facilitated by a pharmacist in a renal clinic ambulatory care setting

5-240 - Evaluation of monitoring and treatment practices for metabolic bone disease in patients with chronic kidney disease: comparing primary care and nephrology clinic settings

8-017 - Evaluation of naloxone prescribing patterns following pharmacist intervention through the use of electronic health record messaging

8-195 - Evaluation of nutritional knowledge among patients with diabetes in Mississippi

6-057 - Evaluation of outcomes of a pharmacist-run insulin titration telepharmacy service at a local ambulatory care clinic.

5-123 - Evaluation of pharmacist impact on hemoglobin A1c in suburban family health centers

3-078 - Evaluation of prescribing patterns of basal insulin as back-up for insulin pump users

3-128 - Evaluation of sodium-glucose cotransporter-2 inhibitor (SGLT-2I) prescribing patterns for type 2 diabetes in the primary care setting

5-304 - Evaluation of statin prescribing in patients with cardiovascular disease and/or diabetes in a primary care clinic with an embedded clinical pharmacy specialist

8-064 - Evaluation of the follow-up rate in patients with pre-diabetes on metformin versus lifestyle modifications

3-429 - Evaluation of the management of the valsartan recall at a rural West Virginia family medicine clinic

6-035 - Evaluation of the relationship between health literacy and duration of diabetes on anti-diabetic injectable administration, storage, and disposal techniques

3-067 - Evaluation of transition of care post-discharge medication reconciliation by patient aligned care team pharmacists

3-039 - Examining the demographics of pharmacy students who participate as medical staff at camps for children with type-I diabetes across the United States

2-147 - Fourth-year student pharmacists-led prescription renewal authorization process in collaboration with medical resident physicians at a family medicine clinic

6-236 - Genetically modified organisms: impact on health, economy, and environment

3-378 - Glycohemoglobin trajectory in adults with type II diabetes mellitus

2-033 - How does Medical or Recreational Marijuana affect Warfarin Dosing?

3-242 - Identifying barriers to therapy initiation of direct-acting oral anticoagulants in a pharmacy consult service at a veteran's hospital

6-026 - Impact of a biometric screening program on eating habits and physical activity

2-296 - Impact of Clinical Pharmacy Services on Pneumococcal Vaccine Administration in a Family Medicine Clinic

3-215 - Impact of comprehensive medication management in an interprofessional diabetes center

6-430 - Impact of deprescribing interventions on health-related outcomes in elderly patients: A scoping review

8-213 - Impact of early detection and post treatment culturing of Pseudomonas aeruginosa in cystic fibrosis patients

3-264 - Impact of ethnicity on glucose control and weight loss after gastric bypass surgery in obese patients with diabetes

6-285 - Impact of hypertension guidelines change on pharmacist led clinic efficacy

6-334 - Impact of interdisciplinary efforts on opioid tapering in a family medicine clinic

8-128 - Impact of interprofessional collaboration on diabetes care on the Governor's Wellmobile

5-053 - Impact of ketogenic diet on glycated hemoglobin and fasting blood glucose: A meta-analysis

8-138 - Impact of liraglutide on hypertension: a retrospective case series

3-113 - Impact of pharmacist care on clinical inertia in diabetes medication management

2-052 - Impact of pharmacist-led diabetes self-management education service

8-191 - Impact of pharmacy intern-led medication therapy management (MTM) services for patients in an outpatient hemodialysis clinic

3-375 - Implementation and Analysis of a Comprehensive Medication Review Protocol and Collaborative Practice Agreement in a Federally Qualified Health Center

3-188 - Implementation of a continuous glucose monitor workflow in an ambulatory care clinic

5-353 - Implementation of a pharmacist-led fracture liaison service for primary prevention within a rural veteran population

8-073 - Implementation of a pre- and post-immunization survey in an ambulatory care clinic: a script for success in patient immunizations

2-366 - Implementation of a smoking cessation initiative in an urban primary care setting

2-134 - Implementation of a student pharmacist-led medication reconciliation program in a student-run free clinic, utilizing the Plan Do Study Act (PDSA) cycle

8-069 - Implementation of a telephone-based pharmacist-led hypertension monitoring program in an outpatient clinical setting

6-369 - Improved glycemic control of long-standing type 2 diabetics on basal-bolus insulin therapy with c-peptide guided glucagon-like peptide-1 (GLP-1) agonist substitution of prandial insulin

2-095 - Improving medication access through the implementation of a pharmacy student led patient assistance program

2-216 - Improving peak flow in children with asthma through utilization of pharmacy students and residents at Camp Huff‘n Puff

3-403 - Improving Transitions of Care Communication: Inpatient to Community Pharmacist Handoff

8-081 - Incidence of antibacterial prescribing for upper respiratory tract infections and bronchitis in a rural outpatient setting

8-025 - Increasing pneumococcal vaccination rates at a family medicine clinic to meet value-based healthcare metrics: a retrospective analysis

8-107 - Keeping current: adherence to updated guidelines for chronic obstructive pulmonary disease

5-178 - Lean Process Improvements for MiRxExpress: A Bedside Medication Delivery Service

8-354 - Lifetime weight trajectory, weight triggers and their association to successful weight loss after bariatric surgery

8-365 - Long-term clinical outcomes of pharmacist-led care in diabetes

6-110 - Management of and deprescribing chronic proton pump inhibitor therapy in an internal medicine clinic

2-104 - Measuring student pharmacist impact with tracking and addressing quality data metrics in a rural based family medicine clinic

2-232 - Medication use evaluation of primary atherosclerotic cardiovascular disease (ASCVD) prevention in an ambulatory care setting

6-065 - Medication-induced syndrome of inappropriate anti-diuretic hormone secretion

8-215 - Motivators and tools of smoking cessation used by former and current smokers

6-034 - Number of patients meeting hypertension goals in a rural pharmacist-led clinic

5-051 - Optimal duration of rest between blood pressure readings

2-444 - Optimizing medication therapy management in patient-centered medical home clinics

6-318 - Outcomes of an interprofessional hepatitis c clinic in primary care

2-031 - Pathway to successfully manage diabetes from the eye of a Clinical Pharmacist in Primary Care

8-158 - Patient perceptions of care given by student pharmacists in the ambulatory care setting

8-110 - Patient Perspectives on Barriers to Medication Adherence and Drug Utilization Post-Discharge

3-394 - Patient perspectives on pharmacist-led comprehensive medication reviews during transitions of care

8-310 - Patient satisfaction on warfarin vs. apixaban treated at a public hospital center

6-180 - Patient-perceived benefits of medication therapy management (MTM) services

2-192 - Persistence and progression: what happens to patients less than 55 years old initiated on an angiotensin-converting-enzyme inhibitor or angiotensin-II receptor blocker for hypertension in Scotland?

6-376 - Pharmacist impact in an ambulatory care setting on patient's diabetic goals

2-131 - Pharmacist-led handoffs to aid in reducing readmissions and medication errors – a comprehensive quality improvement project for safer transitions (PHARM-ACIST)

3-362 - Pharmacists’ role in improving statin therapy in patients with type 2 diabetes 40 to 75 years of age at a community health center.

3-397 - Pharmacy led population health management hepatitis C viral screening: identifying and contacting veterans born between 1945 and 1965

3-408 - Pharmacy review of patient candidacy for conversion from warfarin to direct-oral anticoagulant therapy (DOAC) at one rural family medicine clinic

6-208 - Pharmacy student intervention to obtain affordable insulin for a patient with low-income

6-004 - Pharmacy students as educators: an interprofessional approach to insulin management education

8-390 - Pharmacy’s role in the Million Hearts initiative to decrease 10-year atherosclerotic cardiovascular disease (ASCVD) risk

3-164 - Physician perceptions of lifestyle characteristics, care complexity, and blood pressure goal achievability for family medicine patients with hypertension

6-012 - Physicians’ perceptions of pharmacist collaboration in primary care

6-154 - Population-based diabetes management utilizing employed student pharmacists and residents: an update

6-426 - Potential relationship between acute kidney injury (AKI) and fluctuation of international normalized ratio (INR)

6-202 - Preconception: pharmacist’s role to optimize future pregnancy outcomes

8-125 - Preparing for outpatient antibiotic stewardship: prescribing patterns in family medicine practice

3-010 - Prescribing habits of citalopram at El Rio Health Center for patients older than 60 years of age

6-247 - Probiotics: what healthcare professionals need to know

2-165 - Quality Improvement Findings from an Opioid Storage and Disposal Medication Therapy Management Targeted Intervention Program

3-416 - Quality improvement of Medicare Star Ratings for diabetic nephropathy screenings utilizing pharmacy student intervention in a rural family medicine clinic

3-287 - Rates of statin use for secondary prevention of atherosclerotic vascular disease (ASCVD) and variables related to low use

8-421 - Reducing proton pump inhibitor usage for gastroesophageal reflux disease diagnosis

8-275 - Reducing the inappropriate use of long term proton pump inhibitors to mitigate the potential of long term complication

8-352 - Response: Weight triggers and their association to successful weight loss after bariatric surgery

8-290 - Retrospective analysis of compliance with new hypertension guidelines in an ambulatory care clinic

2-450 - Retrospective analysis of comprehensive diabetic care of patients at the University of Wyoming Family Medicine residency program at Cheyenne

3-092 - Retrospective analysis of discharge prescribing and the impact on transitions of care

6-441 - Role Analysis of Pharmacists in Office-based Opioid Treatment Centers

3-097 - Role of an ambulatory care pharmacist in the management of patients with type 2 diabetes obtaining a goal hemoglobin A1C of 7 percent or lower

8-330 - Role of Self-Monitoring Blood Glucose (SMBG) in Improving Hemoglobin A1c levels in Non-insulin Dependent Patients with Type 2 Diabetes (T2DM): A Systematic Review

3-135 - Should paricalcitol be used as adjunctive therapy to renin-angiotensin-aldosterone system inhibition for diabetic nephropathy? A review of the literature

6-211 - Signs of acute cognitive decline associated with high-intensity and moderate-intensity statin use

3-142 - Slowing progression of chronic kidney disease in diabetic patients using ACEI/ARB therapy

6-212 - Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for Type 1 Diabetes: Giving Patients with Type 1 Diabetes More Therapeutic Options

2-258 - Spontaneous erections associated with venlafaxine

6-308 - Statin underutilization in primary care patients with diabetes

8-396 - Student pharmacist led treat-to-target telephone clinic protocol for diabetes management

2-107 - Student pharmacist role in transitions of care following acute level visits for a rural family medicine clinic

5-348 - Survey of knowledge regarding hypertension and stroke on blood pressure management practices in underserved community health clinics in Ekumfi, Ghana

6-232 - Sustained A1C reduction up to six years in patients with type 2 diabetes managed by pharmacy faculty and PY4 students

6-213 - Sweet success for chronic kidney disease: are sodium-glucose cotransporter-2 inhibitors ready to take the spotlight?

3-402 - Systematic identification of an additional primary care pharmacist service within an academic medical center

8-281 - Tackling third-party payers’ formulary changes to prevent gaps in care for patients with diabetes

2-076 - The retrospective evaluation of rhabdomyolysis in an ambulatory care setting during an advanced pharmacy practice experience (APPE)

6-336 - The Utility of Continuous Glucose Monitoring in the Primary Care Setting

6-087 - Therapeutic drug monitoring of testosterone therapy in the treatment of primary hypogonadism

2-127 - Utilization of adipose stem cell therapy in the treatment of diabetes mellitus

2-035 - Utilization of electronic quality improvement platform for plans and pharmacies (EQuiPP) to target patients for medication therapy management

6-233 - Utilization of Insulin Patch Pumps in Type 2 Diabetes Mellitus

3-189 - Utilization of Nebraska’s prescription drug monitoring program (PDMP) to identify and prevent prescription drug errors in an outpatient clinic

8-035 - Virtual pharmacist consultation services in an ambulatory care setting: a multisite pilot

5-327 - Who is the type 1 adult diabetes patient of the future: characteristics, comorbidities, concomitant medications and costs

8-368 - Aldosterone antagonist monitoring in patients with heart failure at a Veteran Affairs medical center

2-318 - AM vs. PM post-operative administration of warfarin in patients with a mechanical mitral valve

8-192 - Amiodarone-Induced Cirrhosis: A Well-Known Entity, But Yet Underappreciated and Under-recognized Complication

5-346 - Analysis of anticoagulation services in the pediatric population at Johns Hopkins Hospital

8-418 - Analysis of time in therapeutic range (TTR) and antiplatelet dose correlation to gastrointestinal bleeding in patients with continuous flow left ventricular assist device (LVAD) support

6-160 - Anticoagulation prescribing patterns following pulmonary embolism response team consult at a tertiary care center

8-007 - Appropriate utilization of heparin-induced thrombocytopenia (HIT) antibody testing based on 4Ts risk assessment

6-043 - Assessing antithrombotic stewardship in a family medicine clinic: prescribing habits of direct-acting oral anticoagulants (DOACs)

8-072 - Assessment of serum calcium and blood pressure in patients with hypertensive crises: a case-control study

5-305 - Assessment of the impact of pharmacists’ interventions in an advanced heart failure discharge clinic

6-335 - Association between novel circulating biomarkers of cytochrome P450-derived eicosanoid metabolism and prognosis in patients with established atherosclerotic cardiovascular disease

8-075 - Association of serum magnesium and blood pressure in hypertensive crises patients: a retrospective cohort study

6-251 - Benefits of using fixed dosing versus weight-based dosing of 4-factor prothrombin complex concentrate (4F-PCC) in the reversal of anticoagulants

3-093 - Bleeding rates of veterans taking apixaban or rivaroxaban for atrial fibrillation or venous thromboembolism

6-220 - Bridging anticoagulation in patients with atrial fibrillation: A retrospective medication use evaluation

6-257 - Case Report of A Second Myocardial Infarction Due to Improper Transition of Care

8-351 - Characterization and factors influencing medication treatment concordance with heart failure guidelines in patients admitted for heart failure to a Hospice Program

6-136 - Characterization of the use of apixaban in obese patients with non-valvular atrial fibrillation or atrial flutter at an academic medical center

6-016 - Comparative efficacy of antiarrhythmics in the secondary prevention of atrial fibrillation after cardioversion

5-276 - Comparative look at route of phytonadione administration as related to desired time of onset and relative efficacies in rural inpatient hospital setting

2-297 - Comparing extended and immediate release oral diltiazem post intravenous conversion for the treatment of atrial fibrillation

3-060 - Comparing the incidence of surgical site infections (SSI) using narrow versus broad-spectrum perioperative antibiotic prophylaxis in Mechanical Circulatory Support (MCS) patients

8-134 - Comparison of Metoprolol and Diltiazem for Acute Management of Atrial Fibrillation in Patients with Heart Failure with Reduced Ejection Fraction

6-414 - Comparison of the frequency of aldosterone synthase polymorphism (CYP11B2 -344 T>C) in a Caucasian population with atrial fibrillation versus a control group.

3-333 - Comparison of two enoxaparin venous thromboembolism prophylaxis dosing strategies in severely obese patients

2-064 - Concurrent evaluation of a heparin protocol in a large academic tertiary medical center to ensure patient safety and identify areas for improvement

8-113 - Cost-effectiveness of alirocumab compared to evolocumab and ezetimibe in patients with atherosclerotic cardiovascular disease

8-328 - Cost-effectiveness of Rivaroxaban: A Systematic Review

6-397 - Daptomycin-associated false prolongation of International Normalized Ratio in a mechanical mitral valve patient

2-351 - Delayed heparin-induced thrombocytopenia (HIT) in a patient with polycythemia vera (PV)

3-126 - Description of anticoagulation use and risk factors in patients with atrial fibrillation in a pharmacist-managed anticoagulation clinic in rural, western Kenya

3-118 - Determining pharmacists’ ability to detect atrial fibrillation by utilizing mobile single-lead electrocardiogram systems in “Know Your Pulse” awareness campaigns

5-118 - Differential Effects of Intravenous Bolus Furosemide and Continuous Furosemide Infusion and Short and Long-Term Mortality Among Patients Admitted With Acute Decompensated Heart Failure

3-372 - Direct oral anticoagulant plus antiplatelet therapy: Prescribing practices and bleeding outcomes

8-013 - Effect of aspirin on cardiovascular events and major hemorrhage in healthy elderly patients

5-223 - Effect of Chemotherapeutics on G Protein-Coupled Receptor Kinase Expression Levels in Human Cardiomyocytes

2-392 - Effect of concomitant administration of clopidogrel and proton pump inhibitors on bleeding in CYP2C19-genotyped patients who underwent percutaneous coronary intervention

3-016 - Effect of depression on health behavior among myocardial infarction survivors in the United States

3-400 - Effect of mineralocorticoid receptor antagonist initiation on ejection fraction in post-myocardial infarction patients with a reduced ejection fraction

3-245 - Effect of post-traumatic stress disorder on morbidity and mortality in veterans with heart failure

6-007 - Effect on INR when substituting generic warfarin for brand name in the inpatient setting: a case report

3-370 - Effectiveness of a capped weight based acute coronary syndrome heparin protocol

3-194 - Effectiveness of antithrombotic therapy-related transitions of care with a focus on handoff communication

2-372 - Effectiveness of direct oral anticoagulants for the treatment of venous thromboembolism in obesity

2-391 - Effectiveness of genotype-guided antiplatelet therapy versus treatment-as-usual for patients undergoing percutaneous coronary intervention

3-159 - Efficacy and safety of high-dose versus standard-dose subcutaneous unfractionated heparin for the prevention of venous thromboembolism in obese hospitalized patients

2-263 - Efficacy of weight-based prophylactic enoxaparin in preventing venous thromboembolism in obese patients

2-184 - Estimating adherence to direct oral anticoagulant therapy and its effect on all-cause mortality

8-433 - Evaluating frequency of asthma exacerbations in asthmatic patients on cardioselective beta-blockers

8-135 - Evaluating the impact of right heart catheterization on the management of patients with acute decompensated heart failure

3-234 - Evaluating the safety and efficacy of anticoagulation therapy in obese patients

6-288 - Evaluation and assessment of heart failure management in the elderly

2-145 - Evaluation of a medication reminder program designed to optimize patient adherence to direct oral anticoagulants (DOAC)

6-095 - Evaluation of a pharmacist managed warfarin dosing service in a community hospital

2-161 - Evaluation of a pilot MTM program with inpatient cardiovascular services in an academic medical center

3-059 - Evaluation of a weight-based heparin dosing protocol in obese patients

2-367 - Evaluation of a weight-based unfractionated heparin dosing protocol using actual body weight and adjusted body weight in obese patients

6-051 - Evaluation of amiodarone use in patients undergoing coronary artery bypass graft surgery

3-107 - Evaluation of angiotensin converting enzyme inhibitor/angiotensin receptor blocker (ACEi/ARB) and beta-blocker reinitiation post-hospitalization with acute decompensated heart failure

2-136 - Evaluation of anticoagulation related adverse avents in patients in Kauai

8-074 - Evaluation of antiplatelet therapy for ischemic stroke in the african american population

2-389 - Evaluation of bleeding associated with genotype-guided antiplatelet therapy versus usual care for patients undergoing percutaneous coronary intervention

8-420 - Evaluation of differing activated partial thromboplastin time goal ranges with heparin-based purge solutions for patients receiving Impella percutaneous ventricular assist device support

3-280 - Evaluation of direct oral anticoagulant management in an academic internal medicine clinic

3-178 - Evaluation of heart failure education consults and readmission rates at an Urban Safety-Net Hospital

3-109 - Evaluation of non-vitamin k oral anticoagulants (NOAC) hospital discharge prescriptions and follow up

6-075 - Evaluation of oral anticoagulation therapy in hospitalized patients

6-358 - Evaluation of outpatient anticoagulation bridging after left ventricular assist device (LVAD) implantation

3-160 - Evaluation of pharmacy post PCI education at an urban safety net hospital

3-410 - Evaluation of pharmacy-managed argatroban dosing at a large academic medical center

6-427 - Evaluation of prothrombin complex concentrate use for direct oral anticoagulant reversal in intracranial hemorrhage in the emergency department of an academic medical center

3-201 - Evaluation of reduced-dose apixaban utilization in hospitalized patients with nonvalvular atrial fibrillation

5-091 - Evaluation of rivaroxaban prescription adherence rates compared to warfarin for venous thromboembolism at a large teaching hospital

6-289 - Evaluation of the impact of factor Xa inhibitors on heparin-calibrated anti-Xa assays at a large community hospital

8-076 - Evaluation of the relationship between serum magnesium and blood pressures in hypersensitive crises patients: a case control study

8-129 - Evaluation of venous thromboembolism occurrence post prothrombin complex concentrate (human) administration in an academic tertiary medical center

6-011 - Factors correlated with bleeding in patients on direct oral anticoagulants compared to warfarin

6-025 - Factors correlated with gastrointestinal bleeding in patients on direct oral anticoagulants compared to patients on warfarin: a four year analysis

3-106 - Gaps in transitions of care from inpatient to long-term care facilities for patients on oral anticoagulation therapy

2-252 - Heparin induced thrombocytopenia (HIT) treated with rivaroxaban following cardiac surgery

6-379 - How much is too much? A case of severe warfarin resistance

8-145 - Human urinary mRNA as a biomarker of cardiovascular disease: a proof-of-principle study of sodium loading in prehypertension

8-349 - Hypoalbuminemia and bleeding events in patients treated with rivaroxaban

3-034 - Impact of adherence to get with the guidelines-heart failure achievement measures on 30-day hospital readmission

6-230 - Impact of pharmacist-managed initial dosing of direct oral anticoagulants in patients with non-valvular atrial fibrillation

2-377 - Impact of pharmacogenetics on the potential interaction between clopidogrel and proton pump inhibitors

8-405 - Impact of venous thromboembolism prophylaxis in patients with aneurysmal subarachnoid hemorrhage

2-081 - Implementation of a bleeding risk prevention booklet for geriatric patients to enhance knowledge of oral anticoagulation therapy

3-266 - Incidence of bleeding in left ventricular assist device patients at different international normalized ratio goals: 2.0 – 2.5 versus 2.0 – 3.0

8-364 - Influence of sodium-containing antibiotics for bacterial infections on morbidity in patients with heart failure

8-410 - International normalized ratio (INR) variability and gastrointestinal bleeding (GIB) in patients with continuous-flow left ventricular assist device (LVAD) support

6-076 - Intravenous chlorothiazide versus oral metolazone in patients with acute decompensated heart failure admitted to a community hospital

2-106 - Intravenous heparin dosing in obese patients using anti-Xa levels: a retrospective study

2-111 - Limiting adverse events through a pharmacist-based enoxaparin dosing and monitoring protocol: A case study

6-416 - Medical management of non-ST segment elevation myocardial infarction (NSTEMI) patients: use of guideline recommended dual antiplatelet therapy (DAPT)

3-395 - Medication use evaluation to analyze interference of direct oral anticoagulants on monitoring of heparin by anti-factor Xa

8-024 - Medication utilization evaluation of 4-factor prothrombin complex concentrate (4FPCC) at a private medical center in southern Colorado

8-003 - New heparin protocol: a pharmacy-driven implementation of regular and low intensity heparin protocols in a community hospital

3-202 - Overcoming current prescribing barriers to sacubitril/valsartan in a large academic medical center

6-046 - Patient status post cerebral aneurysm clipping and subsequent subarachnoid hemorrhage, of uncertain etiology, requiring acute management for heparin-induced thrombocytopenia and thrombosis: a case report

8-209 - Patients’ willingness to take a polypill for primary prevention and secondary prevention of cardiovascular disease

5-065 - PCSK9 inhibitor utilization, response, and interchangeability within a large integrated healthcare delivery system

2-215 - Perioperative Bridging in Mechanical Valve Patients

8-259 - Persistent Hypotension within One week of Entresto Use; Case Report

8-143 - Physician adherence to 2017 ACC/AHA/HFSA clinical practice guidelines in patients with heart failure with reduced ejection fraction (HFrEF) in a community teaching hospital

6-380 - Potential influence of rivaroxaban on international normalized ratio

6-146 - Potential risk for heparin sensitivity with elevated antithrombin III levels

8-289 - Prevalence and clustering of potentially modifiable risk factors in newly defined categories of blood pressure

8-300 - Prevalence and Trends of Modifiable Risk Factors for Hypertension and Their Associations with the Newly Defined Categories of Blood Pressure

5-104 - Prevalence of type 2 diabetes and prediabetes in underserved Chinese American patients in Chicago, IIlinois

3-040 - Pulse waveform variability in the radial artery

6-387 - Ranolazine in refractory angina in a patient with end-stage renal disease

3-360 - Real-world study of direct oral anticoagulant dosing patterns in atrial fibrillation

6-294 - Recurrent stroke in a patient receiving apixaban prophylaxis for antiphospholipid antibody syndrome: A case report

6-198 - Relationship between household access to balanced meals and presence of cardiovascular disease in the United States

2-045 - Retrospective analysis of warfarin dosage adjustments: Developing a structured approach to warfarin dosing

8-127 - Retrospective chart review of 4-factor prothrombin complex concentrate (4F-PCC) of acute bleeding reversal in adult patients taking non-vitamin K antagonist oral anticoagulants.

8-430 - Retrospective cross-sectional study determining the optimal time to restart warfarin therapy following an upper or lower gastrointestinal bleed

8-409 - Retrospective review of bleeding events in atrial fibrillation patients prescribed warfarin and direct oral anticoagulants post percutaneous coronary intervention

8-119 - Review of pharmacist recommendations for direct oral anticoagulants to assess appropriate use and physician prescribing behavior

6-266 - Review of venothrombosis prophylaxis prescribing patterns and associated outcomes in hospitalized, non-critically ill patients

6-093 - Risk of Heart Failure Associated with Gabapentinoid Use: A Systematic Review of Case Reports and Case Series

6-195 - Rivaroxaban in atrial fibrillation for secondary prevention of stroke: prescribing practices and adverse events

8-121 - Role of testosterone therapy in patients with heart failure: a systematic review

5-219 - Safety assessment of NOACs in non-valvular atrial fibrillation patients

8-108 - Safety evaluation of sacubitril/valsartan in acutely decompensated heart failure

5-334 - Safety of apixaban compared to warfarin in patients with severe renal dysfunction: a retrospective cohort study

3-369 - Self-reported treatment-associated harms in patients with venous thromboembolism

6-179 - Self-testing improves anticoagulation control in a minority population

6-112 - Survey of practices for postoperative atrial fibrillation (POAF) prophylaxis in cardiac surgery

6-175 - The impact of health literacy and health numeracy on quality of anticoagulation control in a minority population

6-305 - The impact of medication adherence in congestive heart failure associated hospitalizations

3-281 - Therapeutic enoxaparin dosing in morbidly obese patients

8-176 - Time in Therapeutic Range of Warfarin in a Population with Intellectual and Developmental Disabilities that is Indicated for Anticoagulation

3-352 - Titrating warfarin to therapeutic international normalized ratio with concomitant use of carbamazepine

3-313 - Trends associated with obtaining anti-Xa levels for apixaban and rivaroxaban in a tertiary, academic medical center

3-359 - Understanding factors associated with Quality of Life (QoL) in patients with venous thromboembolism (VTE)

2-416 - Use of Digoxin Immune Fab (Ovine), a 3.5 Year, Retrospective Review

2-340 - Use of Direct Oral Anticoagulants in Kidney Transplant Recipients at Temple University Hospital

6-242 - Use of patiromer for the treatement of chronic hyperkalemia in heart failure and chronic kidney disease

2-293 - Using Caenorhabditis elegans as an experimental model to test the importance of G protein coupled receptor kinases in controlling the heart's responses to oxidative stress

5-289 - Validation of intravenous heparin protocols in obese patients: full dose and cardiac dose

5-156 - Valuing efficacy of prothrombin complex concentrate reversal of factor-Xa anticoagulants in association with gastrointestinal bleeding

6-197 - Warfarin desensitization: a case report

8-256 - Warfarin resistance with nafcillin co-administration: a case report and review of the literature

6-368 - Adherence to disease-modifying anti-rheumatic drugs in patients in an integrated clinic and specialty pharmacy

5-020 - Assessing patient adherence to chronic medications based on day supply

2-139 - Blue Zones project initiative: changing the environments around pharmacy students

3-371 - Effect of medication adherence on glycemic control in patients with type 2 diabetes

5-318 - Evaluating effects of medications on TGFβ-induced alpha-SMA and fibronectin protein expression in vitro: possible role in idiopathic pulmonary fibrosis

6-319 - Evaluating impact of pre-appointment medication reviews on referrals to a pilot Hepatitis C treatment support program among North Carolina Medicaid recipients in primary care setting

3-367 - Evaluating prescribers' rate of acceptance of community pharmacists' recommendations after providing MTM services

3-330 - Examining metformin adherence in 2017 and discontinuation in 2018

6-170 - Highly efficacious interleukin inhibitors are scarcely prescribed for spondyloarthritides compared to tumor necrosis factor-alpha inhibitors

5-337 - Impact of a pharmacist-led intervention on glycemic control in diabetic patients in a setting with economic constraints

6-215 - Impact of pharmacist initiated transitions of care interventions on emergency department visits and hospital readmissions

6-185 - Implementation of pharmacogenomic testing in a single-center health system: a retrospective review

8-222 - Medicare Part D coverage of phosphate binders

2-072 - Medtopia 360: Educationally priming patients for success

6-417 - Metformin prescribing in type 2 diabetes patients with renal dysfunction in an outpatient internal medicine office

8-246 - Obstructive sleep apnea: raising awareness of a treatable national health burden

8-077 - Patterns of acculturation as predictors of hypertension among Arab immigrants in Southeast Louisiana

5-343 - Quantifying the Expression of HIF-1 alpha and Collagen IV in Urinary Cells of Chronic Kidney Disease Patients After PHD-I Treatment Using Flow Cytometry

3-127 - Rates of depression, anxiety, and diabetes distress among college students with type 1 diabetes

2-097 - Renin angiotensin system antagonist medication copayments effect on Medicare Part D patient adherence and health plan star measures

8-429 - Retrospective case-control study of the incidence of morning hypoglycemia following administration of evening sliding scale insulin

5-041 - Role of a pharmacy student in a Veterans Affairs hypertension management program for rural Veterans

6-084 - Tracking opioid claims since CDC guideline for prescribing opioids for chronic pain

5-342 - Using immunocytochemistry to show the expression of HIF-1 alpha and collagen I/III in renal tubular cells of chronic kidney disease patients after PHD-I exposure

8-313 - Utilizing pharmacogenomic testing to modify therapeutic regimens in patients in a community practice setting

2-055 - What is the efficacy of NGAL when compared to standard of care in early detection of acute kidney injury?

3-013 - Analysis of cost implications and potential adverse events prevented by interventions of an internal medicine pharmacist

8-065 - Analysis of insurance coverage as a positive predictor for duration of PrEP therapy in an urban based clinic serving the LGBTQIA community

6-111 - Analysis of the predictive value of a readmission risk assessment tool to determine utility in clinical pharmacy practice

2-316 - APPE student impact on transitions of care services for patients identified using a modified MARQUIS criteria

3-401 - Assessing knowledge and customizing referral resources for community pharmacy adherence services

2-400 - Assessing physician perceptions of a transition of care pharmacy service

8-232 - Assessing the implementation of a data-mining clinical alert and documentation system as a tool for antimicrobial stewardship outcomes in a community hospital

2-085 - Assessing the relationship of comprehensive medication review completion rates and medication adherence rates within Medicare Part D

2-441 - Assessing tobacco cessation practices in Spokane County: a public health initiative

2-411 - Assessment of community pharmacy perceptions regarding hospital pharmacy-based transitions of care programs

6-314 - Assessment of patient population differences at rural satellite family medicine clinics

3-002 - Assessment of pharmacist intervention and counseling on 30-day readmissions in heart failure patients

8-216 - Assessment of student pharmacist perception’s and implications to treatment to those who may have a substance use disorder, a pilot study

5-160 - Characterization of clinical metrics associated with a medication history program at The Johns Hopkins Hospital

6-384 - Characterization of discrepancies identified by pharmacists conducting discharge medication reconciliation with a family medicine team in an academic medical center

3-102 - Clinical and financial outcomes associated with a pharmacist-coordinated outpatient antimicrobial therapy program in a community hospital setting

6-326 - Clinical impact of medication assistance program enrollment of patients into manufacturer free drug programs

5-363 - Clinical outcomes of a pharmacist-driven medication reconciliation process at a large academic medical center

2-019 - Commonly used service-terms in pharmacy practice: trends, ambiguity and overlap

5-194 - Comparison of a two-phase pulmonary function test (PFT) activity utilizing nose clips and not utilizing nose clips

8-026 - Cost benefits and clinical impact of a pharmacy intern-led inpatient clinical service

6-293 - Cost reduction associated with comprehensive medication reviews in a free clinic population

3-170 - Demographic and patient characteristic evaluation of no-show rates in Veteran Affairs pharmacy-based primary care clinics

8-326 - Descriptive Analysis of Glen Falls Medical Mission Spring 2018

5-025 - Determining patient-specific barriers to using the El Paso Veteran Affairs Health Center and offering a possible solution: telehealth

5-146 - Drug shortage costs and mitigation techniques in a community hospital

6-172 - Evaluating health literacy of patients seen during Jamaica Dental Mission Trip

6-158 - Evaluating patients' total daily acetaminophen dose when prescribed for dental pain management in a dental clinic

6-291 - Evaluation of a pharmacist-directed penicillin allergy documentation initiative within a long-term acute care hospital

6-438 - Evaluation of a pharmacy based antimicrobial renal dose adjustment protocol at a community hospital

8-029 - Evaluation of a transitional care program of bedside delivery of discharge medications at a level 1 trauma center

2-133 - Evaluation of medication errors identified by pharmacists during discharge medication reconciliation

2-261 - Evaluation of patient assistance program utilization in a student run clinic: a review of available process streamlining programs

8-308 - Evaluation of transition of care services available pertaining to the social determinants of health in the surrounding neighborhoods of a safety-net hospital

3-383 - Fecal microbial transplantation in patients with recurrent or refractory Clostridium difficile infection: analyses of patient follow-up in an outpatient clinic setting

3-342 - Healthcare utilization and cost expenditures for pneumonia in individuals with and without diabetes mellitus in the United States

2-420 - Identifying candidates for metformin re-challenge: a retrospective analysis to evaluate metformin intolerance with individuals who have insulin-dependent type 2 diabetes

8-010 - Identifying community comfortability and knowledge of pharmacists’ role in administering vaccinations

8-041 - iImprove Documentation of Allergy Status

6-059 - Impact of a pharmacy-led transitions of care service on post-discharge medication adherence

2-333 - Impact of comprehensive medication review on medication adherence in Medicaid patients

8-167 - Impact of LACE index-based pharmacist interventions on medication-related 30-day readmission rates

2-089 - Impact of perioperative pharmacy services on prophylactic antibiotic selection

6-069 - Impact of pharmacist-provided standard discharge and follow-up initiative on 30-day readmission rate in chronic obstructive pulmonary disease (COPD) patients

8-404 - Impact of sequential clinical decision support alerts on inappropriate Clostridium difficile testing at a multisite health system

6-371 - Implementation of a direct oral anticoagulant stewardship program at a Veterans Affairs medical center

3-207 - Implementation of clinical pharmacy services in vascular and general neurology practice: an opportunity for pharmacy practice expansion

5-181 - Implementation of pharmacist directed baseline medication assessments for specialty patients

2-038 - Implementation of Pharmacist-driven Naloxone Distribution Services at the Washington D.C. VA Medical Center

8-219 - Improving access to care through a pharmacy-run clinic in a military health system

8-226 - Improving medication therapy utilizing a pharmacy-led medication reconciliation process upon transitions of care in a community hospital

2-217 - Incidence of therapeutic duplications in the inpatient setting of as needed medications

6-419 - Incorporation and evaluation of inter-professional education on spirituality into the curricula of first year pharmacy and physician assistant students

5-264 - Laying the foundations for a clinical pharmacy team managed outpatient parenteral antibiotic therapy (OPAT) program

6-382 - Missed opportunities in identifying and curing hepatitis C in a tertiary care urban hospital

3-289 - Naloxone accessibility without a prescriber encounter under standing orders at community pharmacy chains in Texas

3-054 - Pharmacist intervention in hospital discharge and impact on 30-day readmission

2-220 - Pharmacist intervention in immunization delivery: Pharmacists role in increasing immunization rates in college students

6-186 - Preliminary Findings from a Student-Led Medication Reconciliation Service for Home Dialysis Patients

2-399 - Productivity and data collection analysis of a transition of care pharmacy service

5-201 - Pursuing a partnership for longitudinal pharmacy services across the continuum: a collaboration between acute care, clinic-based and community pharmacists

6-299 - Qualitative analysis of the patient perspective in opioid use disorder using unstructured FDA data sources

2-249 - Strategic implementation of appropriate oritavancin utilization at a community teaching hospital: spending money to save money and improve quality of care

5-344 - Systematic review and meta-analysis of pharmacist-led transitions of care services on the all-cause thirty-day readmission rate of patients with congestive heart failure

6-131 - The effects of pharmacy resident driven transition of care follow-up on hospital readmission rates for high risk patients

2-417 - The Impact of Complete Medication Histories on Patients Admitted to an Acute Care Oncology Service

2-405 - The impact of pharmacy-based transitions of care service on hospital readmission

5-226 - The transplant patients perspective on medication teaching

3-341 - Transitions of care opportunities for a clinical pharmacy service

2-423 - Transitions of care toolkit: developing a streamlined approach to pharmacy-based transitions of care

6-267 - Use of longitudinal pharmacy students in a standardized admission medication history program for a cardiac stepdown unit in an academic medical center

2-328 - Utilization of prescription opioids before and after implementation of a prescription drug monitoring program:based off a medicaid population in New Jersey

2-056 - Value of a student-directed antimicrobial stewardship initiative

8-342 - A case report of bleeding and elevated INR secondary to concomitant tramadol and warfarin administration

8-332 - Acetazolamide: A safe and effective option in the treatment of diuretic induced metabolic alkalosis

2-214 - Acute kidney injury incidence using vancomycin/pipercillin-tazobactam versus vancomycin/non-piperacillin-tazobactam antibiotic combination

8-253 - Acute severe hemolysis following use of isobutyl nitrate in a patient with glucose-six-phosphate-dehydrogenase (G6PD) deficiency

3-111 - Adherence to Guideline Recommended Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Discharged Patients Following a COPD Exacerbation

6-201 - Albumin and furosemide combination for management of edema in nephrotic syndrome

3-270 - An evaluation of combined short-acting monotherapy bronchodilator versus long-acting and short-acting bronchodilator therapy in patients with acute exacerbation of COPD (AECOPD)

2-253 - Analyzing pivotal cardiovascular outcomes trials of sodium-dependent glucose linked transporter 2 inhibitors (SGLT-2Is) to anticipate possible approvals for indications and usage of this class

3-017 - Assessing Arizona pharmacists’ knowledge of and confidence with photosensitizing drugs

8-199 - Association between electrolyte disturbances and length of stay in patients with alcohol withdrawal syndrome

5-330 - Cannabinoids for pharmaceutical use

6-268 - Case of methylnaltrexone for the management of ileus

3-044 - Challenges in access and adherence to specialty medications for chronic inflammatory diseases: a retrospective electronic medical record analysis

2-353 - Cigarette smoke exposure induces acetylated histone 3.3 (AcH3.3) accumulation

2-037 - Clinical pharmacogenomics testing in opioid use disorder management: a retrospective cohort study

6-234 - Clinically relevant drug interactions with cannabis

6-052 - Common drugs, uncommon drug reactions: an assessment of third-year pharmacy student knowledge on pseudotumor cerebri

5-317 - Comparative analysis of rhBMP7 and conventional agents on TGFb and CTGF-induced aSMA assembly: role in idiopathic pulmonary fibrosis

8-020 - Comparison of kidney function estimates for drug dosage adjustments in thirty-five simulated medications

8-258 - Corticosteroids in Pseudomonas Pulmonary Exacerbations (C-PPE study) - in Adult Cystic Fibrosis Patients

2-395 - Dapsone-induced methemoglobinemia treated with oral cimetidine: a case report

3-227 - Defining prescribing practices of anticoagulation reversal in patients requiring emergency intraabdominal surgery: how much is too much?

2-057 - Drug Disposition-related pharmacogenomic biomarkers in clinical pharmacogenetics implementation consortium (CPIC) guidelines

5-312 - Drug regimen individualization for attention deficit/hyperactivity disorder: guidance for methylphenidate and dexmethylphenidate formulations

5-196 - Efficacy and safety of direct oral anticoagulant therapy for the treatment of venous thromboembolism in patients with chronic liver disease

8-435 - Efficacy of lactulose versus a combination of lactulose plus rifaximin in the treatment of hepatic encephalopathy

6-137 - Euglycemic diabetic ketoacidosis (DKA) in a patient taking dapagliflozin after starting a ketogenic diet

6-066 - Evaluation of angiotensin converting enzyme-inhibitor and angiotensin receptor blocker therapy in patients with chronic kidney disease

6-031 - Evaluation of antibiotic allergy status in cystic fibrosis patients

6-249 - Evaluation of diabetic ketoacidosis (DKA) management in a community teaching hospital compared to the 2009 American Diabetes Association (ADA) guidelines

8-345 - Evaluation of GLP-1 agonists: A promising second line therapy to reduce cardiovascular outcomes in Type 2 Diabetes Mellitus

2-430 - Evaluation of hypoglycemic events in correlation to risk factors for future incentives to prevent readmissions in an acute care setting

8-144 - Evaluation of the impact of drug drug interactions between ledipasvir-sofosbuvir and antihypertensives

3-008 - Evaluation of two competing 10-year atherosclerotic cardiovascular disease risk equations: estimated risk and statin benefit compared to clinical practice in the US

3-048 - Evaluation of vancomycin intravenous dosing in obese versus non-obese patients

3-297 - Exploratory analysis of the correlation between opioid overdose mortality rates and naloxone access via standing order in Texas

5-285 - Finding the gap in secondary adherence: the percentage of patients who are unable to refill their new-start medications for chronic conditions received upon discharge

2-047 - Globalization in medical and pharmaceutical literature in the United States

8-399 - Guidelines for drug reaction with eosinophilia and systemic symptoms (DRESS), stevens-johnson syndrome (SJS), and toxic epidermal necrolysis (TEN) caused by psychotropic medications

6-273 - Imipramine serum plasma level monitoring in a patient with altered-mental status: an important consideration for differential diagnosis

3-053 - Impact of change in dextrose protocol used to treat hypoglycemia

3-095 - Impact of education and legislation on opioid prescribing patterns following cesarean delivery

3-185 - Impact of lipotropic injections on weight loss in overweight and obese patients: a retrospective analysis

3-037 - Impact of new vancomycin dosing tool on vanco trough and acute kidney injury incidence in acute care hospital from 2017 to 2018

8-098 - Incidence of continued tobacco abuse in patients with chronic obstructive pulmonary disease after smoking cessation education

5-139 - Influenza vaccination awareness and support among college-age adults

6-091 - Integrating genetic testing and medication therapy management to improve patient outcomes

6-023 - Lacosamide associated hypernatremia

8-091 - Liraglutide as an adjuvant therapy to regular U-500 Insulin in a morbidly obese patient with type-2 diabetes mellitus

6-256 - Low-dose lamotrigine-induced rash: Case report

8-348 - Management of Laparoscopic sleeve gastrectomy candidates with type 2 diabetes mellitus (T2DM): impact of a pre-treatment algorithm

3-351 - Management of skin and soft tissue infections at Baptist Health System

6-276 - Metformin continuation or discontinuation for inpatients with diabetes: a review of the literature

5-126 - Multi-target therapy of cyclosporine and mycophenolate mofetil for the treatment of lupus nephritis in patients with systemic lupus erythematosus

3-335 - National outpatient gastric acid suppressant prescribing in the United States between 2009 and 2015

5-307 - Negative health behaviors contribute to the development of opioid use disorder

3-119 - Outcomes and adherence utilizing a lorazepam continuous infusion protocol for the management of alcohol withdrawal.

2-060 - PGRx Services: a pharmacogenetic approach to individualize pharmacotherapy at community pharmacies

6-078 - Pharmacy-based intervention to reduce 30-day readmission after chronic obstructive pulmonary disease exacerbation at a community hospital: the role of a student pharmacist

3-286 - Pneumococcal vaccination rates and characteristics of individuals receiving the pneumococcal vaccine in the United States

5-149 - Potential solutions to statin-induced myalgia in a patient with clinical atherosclerotic cardiovascular disease when a high-intensity statin is required but intolerable

8-400 - Prevalence of screening for prediabetes treatment

3-210 - Prophylactic medication use in hospitalized patients discharged on concomitant high dose corticosteroids

8-359 - Reticulocyte indices to better inform hemoglobin response of Erythropoiesis Stimulating Agents in Hemodialysis: Hitting the Hemoglobin Bull’s-eye

5-076 - Review of small interfering RNA (siRNA) therapy and prior pharmacotherapeutic options in the treatment of hereditary transthyretin (hATTR) amyloidosis polyneuropathy

8-402 - Skin reactions with antiepileptics, mood-stabilizers, and psychotropics

8-319 - Sunscreen knowledge and use amongst pharmacists and pharmacy students

5-243 - Symptomatic gluten intolerance in a non-Celiac disease patient: a case report

8-242 - Systematic review of L-glutamine for vaso-occlusive pain crises in patients with sickle cell disease

2-028 - Taking a bite out of rabies costs: How pharmacists can facilitate better rabies vaccine practices

2-041 - Targeting HIV-associated inflammation with small molecules

5-049 - The Effects of Glucose Replacement Products on Blood Glucose

2-273 - Therapeutic use of cannabis and cannabinoids in headache disorders

2-410 - Time to effect analysis of insulin R U-500 on hemoglobin A1C: a case series

8-293 - Title: Metronidazole induced encephalopathy – a case report

6-100 - To evaluate patient specific factors associated with a negative histamine control for penicillin allergy skin testing

2-341 - Treatment of Hepatitis C Virus and its Effect on Glycemic Control

8-252 - Treatment of mixed subtype refractory rosacea with low dose isotretinoin: a case report and review of the literature

3-308 - Trends in Metformin Prescribing and Off-Label Prescription Use from 2000 to 2015

2-436 - Use of alteplase for a clogged peritoneal dialysis catheter: a case report

6-277 - Use of vitamin E for the management of severe cramping in a patient on hemodialysis

8-051 - Utilization of antibiotics for spontaneous bacterial peritonitis prophylaxis in adult medicine patients treated for variceal hemorrhage

2-304 - Utilization of potassium supplementation in non-critically ill patients

8-155 - Voriconazole results in high budesonide bioavailability in patients with acute graft versus host disease (aGVHD)

5-016 - When you hear hoofbeats, think of zebras!' A Rare Disease Overview

5-321 - A Study of Complementary and Alternative Medicine Use and Interest in Health Professions Students

3-073 - Accuracy of information provided by vitamin store employees to the public regarding supplements

6-418 - An analysis of the correlation between dietary supplements quality and safety

2-036 - An analysis of the frequency and predictors of side effects resulting from the use of complementary and alternative medicine in Ethiopian immigrants

6-218 - Apple cider vinegar: the juicy details on type 2 diabetes

5-191 - Assessing the risk of herb-drug interaction among patients in select North Carolina clinics

8-068 - Assessment of third year pharmacy students’ knowledge about medical marijuana

8-004 - Colorado community pharmacists' experience regarding patients that use marijuana

5-290 - Complementary approaches for the treatment of chronic obesity using natural products – preclinical assessment of lipolysis in mature rat adipocytes

5-234 - Effect of Grape powder versus Metformin in liver enzyme activities in diabetic mice.

8-089 - Effects of probiotic supplementation on hyperlipidemia: a systematic review

8-082 - Effects of probiotic supplementation on inflammatory bowel disease: a systematic review

5-010 - Effects of solvents on mitragynine and 7-hydroxymitragynine extraction from Mitragyna speciosa, commonly known as kratom

6-019 - Evaluation of clinical trials involving the use of homeopathic medicine in the management of infectious diseases

8-297 - Evaluation of pharmacy students' perception and knowledge of medicinal cannabis

5-239 - Evaluative Study of Ethnopharmacy Use, Efficacy, and Safety in rural Tanzania, Africa.

6-411 - Examining the comprehension, perception and social impact of medical and recreational cannabis use among current and future United States pharmacists

2-319 - Identification and characterization of bioactive compounds in Myrothamnus flabellifolius that specifically target Acute Myeloid Leukemic (AML) cells

8-063 - Impact of formal education on pharmacy students' attitudes regarding the legalization and dispensing of medical marijuana

5-332 - Impact of natural and pharmaceutical combination products on patient perceptions and adherence to medications

5-029 - In vitro and ex vivo effects of silymarin fractions on pro-inflammatory cytokine secretion

3-256 - Investigation of natural products as agents to help combat recurrent urinary tract infections

6-152 - Knowledge and attitudes of pharmacists regarding homeopathy

5-028 - Preclinical Investigation of Middle Eastern Diet as Adjuvant for Pancreatic Cancer Therapy

2-044 - Predictors of flaxseed use in ethiopian immigrants

5-032 - Preliminary studies on the extraction and purification of proteins from bitter melon (Momordica charantia) fruit and over-the-counter bitter melon capsules

3-303 - Primary care conditions treated with complementary and alternative medication in South Texas Hierberias

5-070 - United States Pharmacopeia Admission Evaluation of Chinese Skullcap Root

8-355 - Acute kidney injury associated with vancomycin in combination with piperacillin/tazobactam, cefepime, or meropenem in critically ill patients: a drug-shortage driven quasi-experimental study

2-101 - Acute kidney injury in intensive care unit patients on vancomycin and intermittent infusion piperacillin-tazobactam versus vancomycin and extended infusion piperacillin-tazobactam: a retrospective study

2-164 - Adjunctive clonidine to dexmedetomidine-based sedation in the medicine and trauma/surgery intensive care unit: a case series analysis

8-043 - Analysis of medication errors in ICU in Korea; single center, retrospective study

2-032 - Appropriateness of fentanyl use and other sedatives in intensive care unit settings

5-320 - Assessing the current status of critical-low value alerts for heparin drug monitoring in pharmacy computer systems within South Texas hospitals

6-015 - Assessment of clinical outcomes following guideline-directed sepsis care in a private tertiary hospital: a retrospective cohort study

6-238 - Assessment of the appropriateness of antibiotic selection and dosing in the management of septic shock

6-396 - Assessment of unintentional continuation of medications intended for critical illness after hospital discharge at a community hospital

6-006 - Augmented renal clearance in trauma critical care patients

3-350 - Cardiovascular concerns with antiemetic use in pregnancy induced hyperemesis gravidarum

2-198 - Changes in pre-albumin levels in critically ill patients receiving early parenteral (less than 48 hours) versus late (greater than 48 hours) enteral nutrition

6-118 - Characterization of medications as a source of fluids in the medical intensive care unit

6-389 - Characterization of platelet count following traumatic injury

6-114 - Characterization of thrombocytopenia using a low dose heparin anticoagulation protocol for Impella CP devices in cardiogenic shock

3-388 - Correlation of the intensive care unit acuity scoring tool with the Rothman Index in surgical intensive care unit patients

3-374 - Defining Clinically Relevant Opioid Sparing Effects of Ketamine in the Peri-Operative Period

3-376 - Development of a Required Reading List to Facilitate Layered Learning on a Critical Care Rotation

2-284 - Dose comparison of vasopressin in septic shock

5-166 - Drug use evaluation of vasopressin in patients with diagnosis of septic shock in the intensive care unit (ICU) at Peninsula Regional Medical Center (PRMC)

2-266 - Effect of delayed second dose antibiotics on clinical outcomes in patients with sepsis: a retrospective study

5-006 - Effect of treatment strategy on clinical outcomes in candidemia associated septic shock detected using magnetic resonance assay

2-080 - Effect of vitamin c on dose reduction of vasopressors for sepsis patients in the intensive care unit

2-119 - Effectiveness of a computerized order set on diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic syndrome (HHS) outcomes

2-272 - Effects of long-term androgenic-anabolic steroid use on the clinical course of a critically ill patient

2-385 - Evaluating a dexmedetomidine stewardship initiative in a large academic medical center

5-039 - Evaluating of the Impact of Using Multiplex Polymerase Chain Reaction for the Identification of Pathogens in Septicemia Patients at a Community Hospital

8-101 - Evaluating the Impact of Implementing Pediatric Medication Dosing Guides in a Community Hospital’s Emergency Department

2-383 - Evaluating the necessity of central venous catheter placement for patients requiring vasopressor infusions

6-074 - Evaluation of a prophylactic amiodarone protocol for postoperative atrial fibrillation after cardiac surgery

8-197 - Evaluation of a protocol-driven approach for the management of diabetic ketoacidosis in the intensive care unit

2-422 - Evaluation of Alteplase Prescribing Practices in Patients with Acute Pulmonary Embolism

6-072 - Evaluation of an analgosedation protocol in adult trauma patients on mechanical ventilation

8-100 - Evaluation of an insulin infusion protocol in adult patients in the cardiac intensive care unit

6-123 - Evaluation of differences in fluid and vasopressor use based on presence of left ventricular dysfunction in septic patients at an academic medical center

6-353 - Evaluation of high dose versus standard dose dexmedetomidine use in the intensive care unit: exploration of APACHE II score, reason for admission and cost

6-079 - Evaluation of high-dose hydroxocobalamin compared with methylene blue for vasoplegic syndrome post cardiothoracic surgery at a community hospital

2-390 - Evaluation of induction and neuromuscular blocking agents use and adverse drug reactions during and post rapid sequence intubation by physicians

3-186 - Evaluation of intrapleural alteplase plus dornase alfa in the treatment of parapneumonic effusion and empyema

2-349 - Evaluation of pain recall in patients receiving mechanical ventilation in the intensive care unit

6-024 - Evaluation of potassium binder prescribing practices upon hospital admission and effect on serum potassium

3-153 - Evaluation of stress ulcer prophylaxis in critically ill patients

3-179 - Evaluation of stress ulcer prophylaxis therapy in intensive care unit patients at a Midwestern community hospital

3-066 - Evaluation of subcutaneous insulin lispro compared with standard intravenous regular insulin infusion in patients with mild-to-moderate diabetic ketoacidosis

5-270 - Evaluation of timing of intensive care unit delirium onset at a large, academic medical center

5-209 - Evaluation of vancomycin use in the intensive care unit versus medical floors in a community hospital with pharmacist managed therapeutic drug monitoring

5-121 - Factors associated with new-onset atrial fibrillation in critically ill patients with septic shock

6-115 - Fluid resuscitation strategies and clinical outcomes in septic shock patients with heart failure

6-013 - Glycemic control with long-acting insulin in the setting of chronic kidney disease in hospitalized patients

2-384 - Home deliriogenic medication effect on delirium development in a medical intensive care unit

2-268 - Impact of an insulin infusion dose limit on rates of hypoglycemia and time to recovery in the treatment of hyperglycemic crisis

3-099 - Impact of enoxaparin monitoring on incidence of venous thromboembolism in trauma patients

5-119 - Impact of Phenobarbital Loading Dose on Alcohol Withdrawal Syndrome Management

2-286 - Impact of sedation selection on intensive care unit (ICU) length of stay: a retrospective chart review

6-204 - Implementation of a Transition of Care Process in the Medical Intensive Care Unit at an Academic Medical Center

3-043 - Incidence and Characteristics of Hyperglycemia in Critically Ill Adults Prescribed Subcutaneous Insulin: A Retrospective Analysis for Areas of Improvement by Pharmacists

6-097 - Incidence of hypotension requiring intervention associated with stopping vasopressin first in patients with hemodynamic shock on dual vasopressors

6-225 - Incidence of medication-related admissions to the intensive care unit: a single center observational analysis

6-086 - Incidence, treatment, and clinical outcomes of angioedema in the acute care setting

8-417 - Increased cisatracurium dosing requirements in a patient with hyperthermia

5-153 - Intravenous acetaminophen (OFIRMEV®) stewardship in cardiovascular surgery

8-279 - MeRIT Project: Preliminary analysis of the impact of secondary prophylaxis on Clostridium difficile recurrence in the SICU

8-339 - Microscopic Polyangiitis: A Case Report

3-323 - Outcomes associated with utilization of a pharmacy-managed percutaneous ventricular assist device anticoagulation protocol: non-standard purge heparin concentrations

8-243 - Pharmacists’ perception of lithium therapy in the intensive care unit

5-224 - Phenobarbital and lorazepam versus symptom-triggered lorazepam for alcohol withdrawal in the intensive care unit (ICU)

6-244 - Phenobarbital guideline utilization for alcohol withdrawal syndrome

6-259 - Phenobarbital in the treatment of severe alcohol withdrawal

2-162 - Potential etiologies of persistent lactic acidosis in the setting of human immunodeficiency virus (HIV)

2-375 - Predictors of delirium in lightly sedated mechanically ventilated patients

6-391 - Prevalence of cerebral vasospasm associated with degree of glycemic control in patients who have experienced an aneurysmal subarachnoid hemorrhage

3-318 - Ramelteon for decreasing delirium in surgical intensive care unit patients undergoing orthotopic liver transplant

2-248 - Retrospective analysis of dexmedetomidine utilization at a community teaching hospital

5-078 - Retrospective cohort analysis of midodrine as an oral vasopressor in septic intensive care unit patients

8-031 - Rhabdomyolysis, acute kidney injury, and subsequent dialysis therapy in a patient presenting with methamphetamine intoxication

2-117 - Risk factors for delirium and association of antipsychotic use with delirium progression in critically ill trauma patients

2-363 - Safe administration of sacubitril/valsartan via nasogastric tube

3-425 - Safety of venous thromboembolism prophylaxis in geriatric trauma patients

2-172 - Severe Legionnaires’ disease and multi-organ dysfunction in an immunocompromised host

8-357 - Severity of acute kidney injury with vancomycin in combination with piperacillin/tazobactam, meropenem, or cefepime

8-150 - Size matters: Monte Carlo dosing simulations of cefepime in critically ill patients with acute kidney injury on continuous renal replacement therapy

2-345 - Succinylcholine Prolonged Muscle Paralysis: A Case Report

2-039 - The Therapeutic Cost Burdens Associated With Managing Sepsis in a Critical Care Setting in the United States

6-388 - Tigecycline to treat Stenotrophomonas maltophilia ventilator-associated pneumonia in a trauma intensive care unit as a result of a drug shortage: a case series

3-035 - Titratable vs. non-titratable insulin infusions for the management of diabetic ketoacidosis

6-090 - Use of atypical antipsychotics in prolonged mechanical ventilation related anxiety

3-101 - Use of high-dose N-acetylcysteine in acetaminophen toxicity

8-033 - Use of immobilized lipase cartridge in adult cystic fibrosis patient with another serious medical diagnosis in the ICU: case report

6-121 - Validation and Utility of a Medication Regimen Complexity Scoring Tool (MRC-ICU) applied to a Surgical Intensive Care Unit

8-229 - Validation of intensive care after thrombolysis (ICAT) score in patients that received alteplase intervention for ischemic stroke

6-352 - Variability of weight-based dosing of vasopressors in critically ill patients

5-301 - A novel risk-based approach to personalizing patient education following pharmacogenomic testing

8-152 - A retrospective analysis of a statin deprescribing algorithm in hemodialysis patients

2-210 - Abaloparatide: new drug review and cost-minimization analysis

6-081 - Acidotic pH or ketones in urine while taking sodium glucose co-transporter 2 inhibitors upon admission at the Medical Center, Navicent Health

8-005 - Adherence rates of the hepatitis A vaccine in a healthcare for the homeless site

5-316 - Adherence to FDA guidance documents on hepatic dosing recommendations for new molecular entities

2-102 - Albumin stewardship initiative: use of albumin with normal saline for fluid replacement in plasmapheresis

2-105 - Albumin utilization in spontaneous bacterial peritonitis

5-291 - Analysis of fluoroquinolone prescribing for upper respiratory tract infections at a federally-qualified health center

8-058 - Analysis of meropenem use before and after implementation of an education action plan at Glenwood Regional Medical Center

6-040 - Analysis of prescription drug patterns of cardiovascular agents post-myocardial infarction in 16 Alabama cities

5-238 - Analysis of the frequency of high-dose versus standard-dose influenza vaccine in confirmed influenza cases during the 2017-2018 influenza season at a community hospital

3-413 - Antibiotic changes in response to procalcitonin levels in adult medicine patients at an academic medical center

2-173 - Antimicrobial prescribing for pediatric patients with upper respiratory infections in the United States

5-308 - Antithrombin III utilization and monitoring within an integrated health system

2-062 - Assessing cefepime drug utilization in patients with a hematological malignancy who developed febrile neutropenia

8-001 - Assessing drug information access and utilization barriers of healthcare professionals to introduce opportunities for electronic clinical decision support services

6-429 - Assessing implementation of hypoglycemia reversal protocol in a community hospital

8-286 - Assessing pharmacy student and pharmacist knowledge on biosimilars and biologics

8-059 - Assessing proper use of antibiotics for uncomplicated and complicated urinary tract infections in the emergency department using an emergency department specific antibiogram

3-257 - Assessing the accuracy of abstracts from three major infectious disease journals

3-326 - Assessing the appropriateness of oritavancin use in treating skin and soft tissue infections in patients presenting to emergency centers of a healthcare system

2-137 - Assessing the effectiveness of a commercially available pharmacokinetics program in achieving desired vancomycin targets: experience from a community hospital in Hawaii

3-317 - Assessing the effectiveness of vancomycin level reminders on the medication administration record

2-082 - Assessing the impact of tobacco cessation utilization in a tertiary academic medical center

8-265 - Assessing the use of dexmedetomidine for sedation in the intensive care unit

2-306 - Assessing use and compliance after implementation of a catheter directed thrombolysis order set for the treatment of acute pulmonary embolism

2-397 - Assessing Veteran Affair patients maintained on febuxostat for chronic gout with cardiovascular disease for therapeutic interchange to allopurinol

6-356 - Assessment and evaluation of a pharmacist-guided warfarin dosing program within a community health system

6-323 - Assessment of adherence to argatroban nomograms at a tertiary academic institution

5-323 - Assessment of formulary compliance to an intravenous heparin standardization protocol at a comprehensive cancer center

3-191 - Assessment of melatonin use in an academic medical center

3-433 - Assessment of patients with hypokalemia/hypomagnesemia upon admission to an academic tertiary care medical center

8-411 - Automatic Therapeutic Substitution Review and Evaluation

5-331 - Beta-lactam allergies and its effect on antibiotic use in surgical prophylaxis at McKay-Dee Hospital

6-184 - Calcitonin Use Evaluation

2-355 - Canagliflozin induced urosepsis: a case report

3-104 - Cardiovascular non-inferiority trials and their adherence to CONSORT guidelines

5-193 - Cash price variability in the top ten prescribed discharge medications in High Point, North Carolina

8-054 - Census review and feasibility assessment for medication reconciliation initiative

5-133 - Characterization of Daptomycin Usage Based on Institutional Guidelines in a Community Hospital

6-122 - Characterization of dornase alfa use at an academic medical center

3-414 - Characterization of electrolyte replacement practice in internal medicine patients at a large academic medical center

5-132 - Characterization of mometasone furoate and formoterol fumarate dihydrate usage based on institutional guidelines in a community hospital

3-221 - Characterizing inpatient dextromethorphan-quinidine usage at a non-profit, multi-hospital health system

8-283 - Characterizing the use of levalbuterol and albuterol in a neonatal intensive care unit at an academic medical center

8-188 - Clinical and economic evaluation of sugammadex versus neostigmine/glycopyrrolate use on postoperative residual curarization

3-240 - Clinical review and cost effectiveness of inhaled medication therapies for asthma and chronic obstructive pulmonary disease

6-341 - Co-administration of intravenous furosemide and albumin for diuretic resistance and albumin appropriateness

8-383 - Combination use of glucagon-like-peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors: the next step in diabetes therapy?

5-261 - Comparing safety and efficacy outcomes of a pharmacy managed warfarin dosing protocol to traditional daily warfarin management by prescribers

2-163 - Comparison of ifosfamide-induced encephalopathy in patients on neurokinin-1 (NK1) receptor antagonists vs. olanzapine in a National Cancer Institute (NCI) designated center

5-077 - Comprehensive Information of Pharmaceutical Resins

8-416 - Comprehensive Review of Continuous Infusion Guidelines at an Academic Medical Center

3-108 - CONSORT evaluation of noninferiority trials involving antineoplastic agents

8-132 - Cost-effectiveness and prescribing patterns of smoking cessation therapy in an integrated healthcare system

2-142 - Cost-savings analysis of a metered-dose inhaler (MDI) to nebulizer therapeutic interchange procedure at a community hospital

2-109 - Critical care medicine continuous IV insulin protocol medication use evaluation

8-294 - Determining the incidence of errors in prescriber ordering of subcutaneous regular insulin for treatment of hyperkalemia and the incidence of hypoglycemia at a teaching hospital

2-157 - DIcipher: teaching drug information skills to high school students at summer camp

8-012 - Drug interactions between protease inhibitors and antidepressants: An analysis of tertiary drug databases and package inserts

2-067 - Drug use evaluation of alteplase in patients with suspected pulmonary embolism in the emergency and intensive care unit

2-360 - Drug Use Evaluation of Triple Antithrombotic Therapy

8-049 - Drug utilization review of enoxaparin for pharmacologic prophylaxis of venous thromboembolism (VTE) in acutely ill medical patients

3-166 - Effect of four-factor prothrombin complex concentrate (4F-PCC) on reversal of oral anticoagulants: a drug-use evaluation

3-011 - Effect of liposomal bupivacaine on length of stay in total knee arthroplasty

2-177 - Effect of lumacaftor/ivacaftor on respiratory and hepatic systems and consequential adverse events in patients with cystic fibrosis homozygous for phe508del-CFTR: a real world lumacaftor/ivacaftor study

2-267 - Effect of varying weight-based dosing protocols on adverse event frequency in obese patients receiving Intravenous Immunoglobulin in inpatient versus outpatient settings

3-238 - Effects of interventions made by a Multi-Disciplinary Opioid Task Force during the ongoing injectable opioid shortage

2-275 - Efficiency of artificial intelligence tool in simplifying drug information search for health care professionals

8-392 - Emerging Trends in Diabetes Care: A Survey of Pharmacist’s Perceptions of Antidiabetic Agents

5-059 - Evaluating consistent alprazolam use in a rural Veteran Affairs healthcare system: application of the Veteran Affairs Pharmacy Benefits Management Academic Detailing Service

5-147 - Evaluating dofetilide prescribing practices in a community hospital after changes in the electronic health system record

2-050 - Evaluating prescription patterns in patients discharged with an HbA1C greater than or equal to 10

2-243 - Evaluating promotional strategies and organizations receiving enforcement letters from the Food and Drug Administration (FDA) from 2009 to 2018

6-104 - Evaluating the appropriate use of four-factor prothrombin complex concentrate at a community health system

8-408 - Evaluating the impact on length of stay of increased opiate use in sickle cell vaso-occlusive crisis in a rural community hospital

3-391 - Evaluating the transition from infliximab to infliximab-abda at an academic medical center

3-324 - Evaluating utilization and adherence of varying levels of statin intensity in a cohort of Medicare Advantage patients with diabetes

6-106 - Evaluation of a Nurse-Driven Electrolyte Replacement Protocol in the Critical Care Setting

2-002 - Evaluation of adherence to albumin criteria for use policy in the Veterans Affairs (VA) Connecticut Healthcare System

6-449 - Evaluation of adherence to an aztreonam stewardship initiative